News
BREAKING! NAFDAC Approves Covid-19 Vaccine Rejected By South Africa For Nigeria

The Oxford/AstraZeneca COVID-19 vaccine has been approved for use by the National Agency for Food and Drug Administration and Control (NAFDAC) in Nigeria.
The vaccine was recently approved by the W.H.O for emergency use, in a press briefing, NAFDAC says it got the dossier of the vaccine a week ago, and the NAFDAC safety committee went to work immediately to evaluate its safety and efficacy for Nigerians.
The Oxford/AstraZeneca vaccine, also known as ChAdOx1 nCoV-19, or AZD1222, is a viral vector vaccine. Scientists used an adenovirus, originally derived from chimpanzees, and modified it with the aim of training the immune system to mount a strong response against SARS-CoV-2 (the virus that causes COVID-19).
However, South Africa had stopped the usage of this vaccine because it wasn’t working effectively.
Details shortly…
-
News2 days ago
BREAKING! CBN, SEC Fine Access Holdings Over N1 Billion For Contraventions
-
News2 days ago
Access Holdings Records 88% Growth in Gross Earnings to N4.878 Trillion
-
News10 hours ago
CSP Fabian Should Be Allowed To Do His Job, Rights Activist Tackles Naysayers
-
News16 hours ago
Access Bank Loses N1.69 Billion To Fraud, Forgery Incidents In 2024